10
Participants
Start Date
May 31, 2012
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
Cannabidiol 400
Subjects in Arm CBD 400 will receive 400mg of Cannabidiol in each of the three test sessions
Cannabidiol 800
Subjects in Arm CBD 800 will receive 800mg of Cannabidiol in each of the three test sessions
Control
Subjects will receive a harmless, inactive pill to compare and validate the results of the other arms of the study
Mount Sinai Medical Center, New York
Hurd,Yasmin, Ph.D.
INDIV